Medical Licensing (MD/DO) · Independent exam preparation
European Diploma in Radiology (EDiR): Free Preparation Guide Study Guide
Practise imaging interpretation, classification thresholds and clinical decisions across the EDiR curriculum with 60 focused concepts, 20 questions and 20 recall cards.
By CertMedbry · Updated 20 October 2026
Practise distinguishing imaging patterns, applying classification thresholds, selecting appropriate investigations and communicating consequential findings. This selective guide develops 60 substantive concepts across 20 curriculum domains. The full examination scope remains the official European Training Curriculum for Radiology, Levels I–II, March 2025 edition, linked by ESR as current on 10 October 2026. EDiR preparation also requires broader image interpretation and clinically oriented reasoning across that curriculum.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
What qualification and training level does this guide address?
This guide addresses EBR's European Diploma in Radiology, based on the European Training Curriculum, Levels I–II. Level I covers training years 1–3 and Level II years 4–5. The separately listed undergraduate and subspecialisation curricula are outside this selected pathway.
EDiR · European Training Curriculum for Radiology: Edition March 2025
How many questions and cases are in the examination?
The EBR examination page describes 78 multiple-response questions, 24 short cases and 10 Clinically Oriented Reasoning Evaluation cases.
How are the examination components scored, and what must candidates pass?
Candidates must pass both assessed parts: the written part and CORE. The written score combines multiple-response questions at 70% and short cases at 30%; these are component weights, not subject-domain percentages. Each part's passing threshold is calculated from the cohort mean minus one standard deviation, bounded at 50–60% for the weighted written score and 55–70% for CORE. Reaching the overall CORE pass mark is only one requirement. Candidates must also complete at least eight of the ten cases and every mandatory case when designated; score at least 5/10 in at least half the cases; have no more than two cases scoring 1.5 or less; and have no more than one unsafe case. Incomplete cases score zero, and unsafe scores count as zero. With one unsafe case, no other case may score 1.5 or less, at most one other case may be failed, and the overall CORE score must reach the applicable pass mark plus five percentage points. The result must then undergo the specified committee review before a pass is confirmed. These additional CORE requirements are set out in EBR terms and conditions, clauses 30–35: https://www.myebr.org/edir-terms-and-conditions.
How long are the components, and where are delivery arrangements specified?
EBR publishes 95 minutes for the multiple-response questions, 90 minutes for short cases and 90 minutes for CORE, with 15-minute breaks between components. Review the instructions for the selected sitting for its delivery and attendance arrangements.
Which curriculum edition and domain distribution apply?
ESR linked the March 2025 Level I–II curriculum as current on 10 October 2026; Sustainability was added in that update. Its publication date should not be treated as a separate examination-specific effective date. This guide gives three concepts, one question and one flashcard to each of its 20 curriculum domains as a study allocation. Consult EBR's examination distribution information for the official subject distribution; the guide's equal allocation does not represent official weighting.
ESR Training Curricula · European Training Curriculum for Radiology: Edition March 2025 · EDiR FAQs
How do the curriculum domains relate to EBR's recurring examination categories?
The curriculum chapters and EBR's recurring examination categories are different organisational schemes. EBR lists abdominal, breast, cardiac, chest/thorax, head and neck, imaging physics including radiation safety, imaging pharmacology including contrast media and radiopharmaceuticals, interventional and vascular, management, musculoskeletal, paediatrics, urogenital and neuroradiology in every examination. The full curriculum remains the scope reference, including subjects beyond this selective guide.
EDiR FAQs · European Training Curriculum for Radiology: Edition March 2025
Do these practice questions reproduce the official examination?
The 20 practice questions are original four-option, single-best-answer drills. Official EDiR formats include multiple-response questions, short cases and CORE cases, so these drills supplement image-based and reasoning practice. Their results do not predict an examination pass.
Does EDiR replace a national qualification or licence?
EDiR is an additional general-radiology qualification operating alongside national structures. Recognition and its relationship to national training or certification depend on the relevant jurisdiction. The listing's administrative category does not establish universal medical licensure.
The European Board of Radiology awards the European Diploma in Radiology, a general-radiology qualification endorsed by ESR and UEMS. The listing label 'Diploma of the European Society of Radiology' refers here to EDiR; it does not establish a separate credential. These independently authored learning materials support preparation and do not confer national medical licensure.
Outline used: European Training Curriculum for Radiology, Level I–II, Edition March 2025, linked as the current curriculum by ESR on 2026-10-10. The workbook label 'Diploma of the European Society of Radiology' maps to the EBR's European Diploma in Radiology (EDiR); the assigned slug is preserved. A separate examination-specific effective date was not stated on the opened EBR pages.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Breast Radiologynot stated
1.When is BI-RADS 0 an incomplete assessment?
BI-RADS 0 means the imaging assessment is incomplete because additional imaging evaluation, prior examinations or both are needed. It expresses an unfinished diagnostic process rather than a probability category for a fully characterised lesion. The next decision is to obtain the missing information and issue a final assessment. Additional views or targeted ultrasound should answer the specific unresolved finding, rather than becoming an automatic sequence for every recall.
Apply it
A screening mammogram shows an asymmetry without available comparisons. Request prior studies and diagnostic assessment appropriate to the finding. Explain that the recall completes interpretation; the screening appearance alone does not establish malignancy.
Common pitfall: Do not translate incomplete assessment into probably benign follow-up. A short-interval surveillance recommendation presupposes adequate diagnostic characterisation, which BI-RADS 0 explicitly lacks.
2.What distinguishes a benign breast assessment from probably benign surveillance?
BI-RADS 2 records a benign imaging finding and supports routine screening appropriate to the patient. BI-RADS 3 describes a probably benign finding for which imaging surveillance is recommended after diagnostic evaluation. The discriminating issue is whether the finding has an established benign explanation or retains limited uncertainty warranting follow-up. A benign assessment of one imaging finding does not automatically explain a clinically suspicious palpable abnormality elsewhere.
Apply it
Diagnostic ultrasound shows a simple cyst exactly corresponding to a mammographic mass. Assign a benign assessment for that concordant finding. If a separate hard palpable area remains unexplained, address that clinical-imaging discrepancy independently.
Common pitfall: Do not choose surveillance merely because a finding is benign. Routine screening and short-interval follow-up communicate different levels of diagnostic certainty and management.
3.Why does a suspicious breast assessment lead to tissue diagnosis?
BI-RADS 4 identifies a suspicious abnormality for which biopsy should be considered; imaging alone has not established its histology. The assessment connects a sufficiently concerning appearance to tissue sampling rather than routine screening or probably benign surveillance. Subsequent management also depends on whether pathology explains the imaging target. A benign tissue result requires concordance review when the sampled abnormality remains suspicious or targeting was uncertain.
Apply it
An irregular breast mass receives a suspicious assessment. Recommend image-guided tissue sampling using the modality that reliably demonstrates the target. After biopsy, compare the pathology with the original imaging concern before concluding evaluation.
Common pitfall: A suspicious assessment does not mean cancer is already proven. Conversely, a benign biopsy label cannot resolve an unexplained suspicious imaging finding without concordance.
ACR Mammography Sample Lay Report Letters · ACR Reporting: Mammography
Cardiac and Vascular Radiologynot stated
4.How does myocardial enhancement distribution distinguish ischaemic injury?
Ischaemic late gadolinium enhancement characteristically involves the subendocardium and may extend transmurally within a coronary distribution. Midwall or subepicardial enhancement that spares the subendocardium supports a nonischaemic injury pattern. Distribution is therefore more discriminating than enhancement alone. Describe location, transmural extent and associated ventricular findings, while recognising that an enhancement pattern narrows the mechanism and must be interpreted with the clinical context.
Apply it
Cardiac MRI shows inferior subendocardial enhancement extending toward the epicardium in a coronary territory. Describe an ischaemic scar pattern and its transmural extent, then assess regional motion and global ventricular function for associated impairment.
Common pitfall: Do not equate every enhancing myocardial segment with infarction. Subepicardial enhancement with subendocardial sparing requires a different mechanistic interpretation from a coronary-territory scar.
5.How should stress perfusion be interpreted alongside myocardial scar?
Stress perfusion evaluates inducible differences in myocardial blood delivery, whereas late gadolinium enhancement characterises myocardial injury or scar. A stress-induced regional perfusion defect without corresponding scar supports inducible ischaemia. A defect confined to established scar has a different implication. Interpret the spatial relationship between perfusion and enhancement, check whether the defect follows a plausible coronary distribution, and assess image quality before classifying an apparent abnormality.
Apply it
A stress study shows a reversible anterior perfusion defect without anterior late enhancement. Report inducible ischaemia in the affected distribution, while separately documenting a small inferior scar that does not explain the anterior perfusion abnormality.
Common pitfall: Do not use normal late enhancement to exclude inducible ischaemia. Scar imaging and stress perfusion answer related but distinct questions about myocardial injury and delivery.
6.How is ventricular ejection fraction related to regional wall motion?
Ejection fraction is stroke volume divided by end-diastolic volume: (end-diastolic volume minus end-systolic volume) divided by end-diastolic volume. It summarises global emptying but does not locate regional dysfunction. Segmental wall-motion assessment can reveal focal hypokinesia or akinesia despite a preserved global value. A useful cardiac MRI interpretation therefore combines ventricular volumes, ejection fraction and regional motion rather than allowing one global number to replace anatomical assessment.
Apply it
A ventricle has an end-diastolic volume of 160 mL and end-systolic volume of 64 mL. Calculate an ejection fraction of 60%, then still inspect each segment because focal motion abnormalities can coexist with preserved global emptying.
Common pitfall: Do not infer normal regional contraction from a preserved ejection fraction. Global compensation can conceal a focal abnormality relevant to perfusion and scar interpretation.
Chest Radiologynot stated
7.Which CT distribution supports a usual interstitial pneumonia pattern?
A usual interstitial pneumonia pattern is supported by basal and subpleural predominant fibrosis, including honeycombing, often with traction bronchiectasis or bronchiolectasis. The distribution and accompanying features matter as much as individual cystic spaces. Imaging pattern classification should also assess features suggesting an alternative diagnosis. A UIP pattern is a radiological pattern; identifying idiopathic pulmonary fibrosis additionally requires the appropriate clinical setting and exclusion of other causes.
Apply it
An older adult's CT shows peripheral basal reticulation, stacked subpleural cystic spaces and traction bronchiectasis, without a dominant alternative pattern. Describe a UIP pattern and integrate exposure, connective-tissue disease and other clinical information before assigning an aetiology.
Common pitfall: Do not equate a UIP pattern automatically with idiopathic pulmonary fibrosis. Other diseases can produce the same fibrotic pattern and require clinical investigation.
8.How can honeycombing be distinguished from traction bronchiectasis?
Honeycombing consists of clustered cystic air spaces in a fibrotic lung, typically subpleural and often arranged in layers. Traction bronchiectasis represents airway dilatation caused by surrounding retractile fibrosis. Following a structure through contiguous sections helps identify airway continuity rather than treating every round lucency as a separate cyst. Distinguishing these findings strengthens fibrotic pattern classification and reduces overcalling honeycombing from a single axial image.
Apply it
Several peripheral round lucencies appear on one CT slice. Scroll through adjacent sections and multiplanar views: branching continuity supports traction bronchiolectasis, whereas clustered layered cystic spaces support honeycombing in the appropriate fibrotic setting on CT.
Common pitfall: A single cystic-looking cross-section cannot establish honeycombing. Dilated airways and emphysematous spaces can imitate cysts unless continuity and surrounding fibrosis are assessed carefully.
9.Which findings should redirect assessment away from a classic UIP pattern?
Marked ground-glass opacity, extensive mosaic attenuation or air trapping, profuse nodules, and an atypical distribution can suggest an alternative to a classic UIP pattern. These findings must be judged in extent and context, because minor accompanying abnormalities do not necessarily outweigh otherwise characteristic fibrosis. The practical decision is whether the dominant morphology and distribution fit UIP or require an alternative-pattern differential and targeted clinical correlation.
Apply it
A fibrotic CT shows substantial upper-lung involvement and extensive lobular air trapping on expiration. Highlight these alternative-pattern clues and seek relevant exposure history instead of assigning UIP solely because some peripheral reticulation is present.
Common pitfall: Do not let the presence of fibrosis end pattern analysis. Its distribution and associated airway or parenchymal abnormalities can change the leading diagnostic pathway.
Emergency Radiologynot stated
10.How does ascending aortic involvement determine Stanford classification?
Stanford type A dissection involves the ascending aorta, regardless of the location of the entry tear or the distal extent. Type B dissection does not involve the ascending aorta. Classification depends on anatomical involvement rather than where the flap is most conspicuous. The distinction has urgent management implications, and the report should also describe extent, branch involvement and complications that influence immediate treatment planning.
Apply it
CTA shows an entry tear distal to the left subclavian artery but retrograde extension into the ascending aorta. Classify the dissection as Stanford type A and communicate the ascending involvement promptly to the treating team.
Common pitfall: Do not classify solely by entry-tear location. A distal tear with ascending extension remains type A because ascending aortic involvement determines the Stanford category.
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease
11.Why is unenhanced CT useful for suspected aortic intramural haematoma?
Intramural haematoma is haemorrhage within the aortic wall and can appear as crescentic or circumferential hyperattenuating wall thickening on unenhanced CT. A conventional flowing false lumen or obvious intimal flap may be absent. Unenhanced imaging helps distinguish acute blood from other wall appearances, while contrast imaging evaluates the lumen and associated complications. The absence of a flap therefore does not exclude an acute aortic syndrome.
Apply it
A patient with abrupt chest pain has hyperattenuating crescentic ascending aortic wall thickening on unenhanced CT. Contrast images show no classic dissection flap. Recognise possible ascending intramural haematoma and escalate the acute aortic finding.
Common pitfall: Do not dismiss acute aortic disease because contrast images lack a flap. Intramural blood may be most conspicuous before contrast administration in the examination.
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease
12.Which dissection findings indicate complications beyond the intimal flap?
Aortic dissection assessment must identify rupture and impaired organ perfusion, not merely demonstrate a flap. Evaluate periaortic haemorrhage, haemopericardium, pleural blood, branch-vessel involvement and downstream organ enhancement. Branch obstruction may arise from flap-related dynamic compromise or extension into the branch itself. Communicating these complications alongside classification and extent supplies information that directly affects urgent management and distinguishes complicated disease from an uncomplicated anatomical appearance.
Apply it
CTA shows a descending dissection with poor enhancement of one kidney and compromised renal arterial inflow. Report the perfusion abnormality and implicated branch anatomy explicitly rather than ending the report with the Stanford category alone.
Common pitfall: Do not assume type B means uncomplicated disease. Malperfusion or rupture can make a descending dissection immediately consequential despite the absence of ascending involvement.
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease
Gastrointestinal and Abdominal Radiologynot stated
13.Which enhancement sequence supports a hepatic haemangioma?
A typical hepatic haemangioma shows peripheral, discontinuous globular enhancement followed by progressive central fill-in on delayed imaging. The enhancing portions resemble the blood pool across phases. This temporal behaviour reflects vascular spaces filling gradually and is more informative than describing a lesion as simply hypervascular. Characterisation should integrate all available phases, lesion morphology and the patient's background risk rather than relying on one arterial image.
Apply it
A liver lesion has peripheral nodular enhancement matching vessels in the arterial phase and progressive inward fill-in later. In an appropriate clinical setting, recognise the typical haemangioma pattern rather than labelling arterial enhancement alone as malignant.
Common pitfall: Do not confuse discontinuous peripheral globules with a continuous enhancing rim. Their morphology and later behaviour support different interpretations and should be described precisely.
EASL Clinical Practice Guidelines on the Management of Benign Liver Tumors
14.When does suspected hepatic haemangioma require contrast characterisation?
The EASL recommendations permit an ultrasound diagnosis of haemangioma in a healthy liver when a lesion is under 3 cm and shows homogeneous hyperechogenicity, sharp margins, posterior acoustic enhancement and no halo. These criteria provide the complete typical ultrasound pattern; echogenicity alone is insufficient. In oncology patients or patients with underlying liver disease, contrast-enhanced characterisation is required. A lesion outside the typical ultrasound criteria also needs further characterisation rather than automatic reassurance.
Apply it
A 2-cm lesion in a healthy liver is homogeneously hyperechoic, sharply marginated, shows posterior enhancement and has no halo. It meets the typical ultrasound criteria. The same finding in a patient undergoing cancer follow-up requires contrast-enhanced characterisation.
Common pitfall: Do not substitute 'small and bright' for the full criteria. The under-3-cm boundary, all four sonographic features and a healthy liver are essential to this ultrasound-only pathway.
EASL Clinical Practice Guidelines on the Management of Benign Liver Tumors
15.How should an atypical liver lesion be handled after incomplete characterisation?
A benign liver diagnosis requires a coherent imaging pattern, not merely one compatible feature. If ultrasound or a limited-phase examination is atypical or insufficient, contrast-enhanced imaging can assess vascular behaviour and improve characterisation. MRI offers additional tissue information when a benign lesion is suspected. Persistent uncertainty should be discussed through an appropriate multidisciplinary pathway, particularly before an invasive procedure is chosen for a potentially benign vascular lesion.
Apply it
A single-phase CT shows an indeterminate enhancing liver lesion that lacks enough information for haemangioma characterisation. Recommend a suitable dedicated contrast examination, comparing prior studies and clinical risk before considering whether tissue sampling is necessary.
Common pitfall: Do not diagnose haemangioma from arterial brightness alone or proceed reflexively to biopsy. Complete characterisation can resolve uncertainty and prevent an unnecessary invasive procedure.
EASL Clinical Practice Guidelines on the Management of Benign Liver Tumors
Gynaecological and Obstetric Radiologynot stated
16.What establishes a definite normally implanted intrauterine pregnancy on ultrasound?
A definite normally implanted intrauterine pregnancy requires a gestational sac containing a yolk sac or embryo implanted within normally located decidualised endometrium, generally in the upper two-thirds of the uterine cavity. Both gestational contents and implantation site matter. Cervical and caesarean-scar implantations are ectopic pregnancies even though they lie within the uterus. An empty intrauterine fluid collection does not provide the same definitive evidence. Location and viability require separate assessment.
Apply it
When a sac contains a yolk sac, confirm its relationship to the endometrium and implantation site before calling it a normally implanted pregnancy. A sac implanted in a caesarean scar or the cervix requires classification as ectopic rather than reassurance based on its uterine position.
Common pitfall: Do not equate 'within the uterus' with normal implantation. Gestational contents in a cervical or caesarean-scar implantation establish an ectopic location, not a normally implanted intrauterine pregnancy.
17.Which ultrasound finding establishes a definite ectopic pregnancy?
A gestational sac containing a yolk sac or embryo in an abnormal implantation location establishes a definite ectopic pregnancy. An adnexal mass alone may be concerning but is not equivalent to directly demonstrating extrauterine gestational contents. Precise location and associated findings should be reported because they influence management. The decisive distinction is between evidence that proves ectopic implantation and indirect findings that raise its probability.
Apply it
Transvaginal ultrasound demonstrates an extraovarian adnexal gestational sac containing a yolk sac, with no intrauterine gestation. Report a definite ectopic pregnancy and communicate promptly, including the location and any associated free fluid that is present.
Common pitfall: Do not treat every adnexal mass as a proven ectopic pregnancy. A corpus luteum or another adnexal lesion can coexist with an early pregnancy.
18.How should pregnancy of unknown location be interpreted?
Pregnancy of unknown location describes a positive pregnancy test with no definite or probable intrauterine or ectopic pregnancy identified on transvaginal ultrasound. It is a temporary classification requiring follow-up, not a final diagnosis of ectopic pregnancy or pregnancy loss. Possible outcomes include an early intrauterine pregnancy, a resolving pregnancy or an ectopic pregnancy. Symptoms, serial biochemical information and repeat imaging guide subsequent classification and urgency.
Apply it
A clinically stable patient has a positive pregnancy test and no identified pregnancy on transvaginal ultrasound. Use pregnancy-of-unknown-location terminology and organise follow-up; new severe pain, collapse or other concerning symptoms require urgent reassessment rather than routine waiting.
Common pitfall: An empty uterus does not independently prove ectopic pregnancy. Equally, uncertain location must not be interpreted as reassurance that an ectopic pregnancy is excluded.
Head and Neck Radiologynot stated
19.How are ACR TI-RADS points assembled from ultrasound features?
ACR TI-RADS combines points for composition, echogenicity, shape, margins and echogenic foci. Solid composition scores two, hypoechogenicity two, taller-than-wide shape three and punctate echogenic foci three; smooth margins add none. The total determines the category before size determines management. Record each feature explicitly so that the category can be checked, rather than assigning a risk label from an overall impression of suspiciousness alone.
Apply it
A solid hypoechoic thyroid nodule is wider than tall, smoothly marginated and contains punctate echogenic foci. Add 2 + 2 + 0 + 0 + 3 = 7 points, placing it in TR5 before applying size thresholds.
Common pitfall: Do not count a descriptive feature twice or infer management directly from points. Risk category and maximum nodule size are separate inputs to recommendations.
20.When do thyroid nodule size thresholds support FNA or follow-up?
Under the ACR TI-RADS chart, TR3 nodules meet FNA criteria at 2.5 cm and follow-up criteria at 1.5 cm. TR4 thresholds are 1.5 cm for FNA and 1.0 cm for follow-up; TR5 thresholds are 1.0 cm and 0.5 cm respectively. Thus, identical nodule sizes can lead to different recommendations because sonographic risk modifies the intervention threshold. Apply the selected system consistently and account for relevant clinical context.
Apply it
A 1.2-cm TR4 nodule has no separate clinical feature requiring a different pathway. It meets the chart's follow-up threshold but remains below its FNA threshold. A 1.2-cm TR5 nodule would meet FNA criteria.
Common pitfall: Do not borrow a biopsy threshold from another risk system. Different thyroid classification systems use different categories and management cutoffs despite superficially similar terminology.
ACR Thyroid Imaging Reporting and Data System · ACR TI-RADS Assessment Categories: Alternative Chart
21.Which echogenic foci contribute differently to thyroid risk scoring?
The ACR TI-RADS chart distinguishes large comet-tail artefacts, macrocalcification, peripheral rim calcification and punctate echogenic foci. Their point assignments are zero, one, two and three respectively. More than one applicable type of echogenic focus can contribute points. Accurate interpretation therefore requires describing the focus and its artefact rather than using the nonspecific word calcification, which conceals differences that can change the final category.
Apply it
Two otherwise similar thyroid nodules contain different echogenic foci: one has large comet-tail artefacts and the other punctate foci. Assign the appropriate different points rather than giving both an identical generic calcification score.
Common pitfall: Do not score every bright focus as punctate echogenic foci. Benign-appearing comet-tail artefacts have a different chart assignment and can otherwise inflate risk categorisation.
Interventional Radiologynot stated
22.Why must patient, procedure and site be reconciled before intervention?
Preprocedural verification links the intended intervention to the correct patient, target and agreed plan. Reconcile identifiers, referral information, relevant imaging, consent and procedural site before beginning. A discrepancy is a reason to stop and resolve the mismatch, not an administrative detail to correct after puncture. The mechanism of harm prevention is independent confirmation across information sources before an irreversible procedural step occurs.
Apply it
The consent describes left renal biopsy, but the scheduling list says right renal biopsy. Review the referral and imaging with the responsible team and resolve the intended target before preparing or puncturing either side.
Common pitfall: Do not let familiarity with the patient substitute for verification. Agreement among staff can still reproduce a shared scheduling error unless source information is reconciled.
23.How does renal assessment influence iodinated contrast intervention planning?
Assess serum creatinine and calculated eGFR, and identify known or suspected acute kidney injury separately; an apparently reassuring eGFR cannot establish stability during evolving AKI. ESUR Guidelines version 10.0 identify increased renal risk at eGFR below 45 mL/min/1.73 m² for intra-arterial first-pass renal exposure and below 30 for intravenous or intra-arterial second-pass exposure; ICU patients also have the below-45 risk threshold. First-pass exposure reaches the renal arteries relatively undiluted, whereas second-pass exposure follows circulatory dilution. Use low- or iso-osmolar iodinated contrast at the lowest diagnostic dose and preventive intravenous saline or bicarbonate hydration when indicated, individualised for heart failure or advanced renal failure.
Apply it
Before angiography, review current creatinine, its trend, eGFR, urine output and the planned injection site. A suprarenal aortic injection produces first-pass exposure, while an infrarenal arterial injection produces second-pass exposure. Suspected AKI requires reassessment regardless of a previous normal result. Begin appropriate preventive measures as circumstances permit without delaying necessary emergency care to obtain laboratory results.
Common pitfall: Do not apply one eGFR threshold to every iodinated contrast route or treat oral fluids alone as preventive hydration. Balance diagnostic urgency, contrast minimisation and intravenous hydration against the patient's risk of fluid overload.
CIRSE Clinical Practice Manual · ESUR-Guidelines-10_0-Final-Version.pdf
24.What makes interventional consent specific to the proposed procedure?
Meaningful consent addresses the proposed procedure, expected benefit, material risks and reasonable alternatives in language the patient can understand. It should connect the intervention to the patient's indication and allow questions before sedation or procedural pressure impairs discussion. A signed form documents part of the process but cannot replace it. Preprocedural assessment also checks whether changes in the clinical situation require the plan and discussion to be revisited.
Apply it
A planned diagnostic angiogram has changed to a possible therapeutic embolisation. Confirm that the patient understands the expanded purpose, relevant additional risks and alternatives before proceeding, and document the updated discussion and agreed procedural scope.
Common pitfall: Do not assume consent for one intervention automatically covers a materially different procedure. The patient's understanding and agreement must match the actual proposed treatment plan.
Musculoskeletal Radiologynot stated
25.When is ultrasound appropriate for initial soft tissue mass triage?
Ultrasound is an appropriate initial triage tool for an accessible, small soft tissue mass, particularly one under 5 cm. It can assess whether the lesion is cystic or solid and whether its appearance supports a confident benign diagnosis. Indeterminate or suspicious findings require further assessment rather than reassurance based on superficial location. Larger, deep or clinically concerning masses often warrant MRI and an appropriate specialist pathway.
Apply it
A patient presents with a small superficial lump that is readily accessible to ultrasound. Use ultrasound to characterise it initially. If the appearance is indeterminate or suspicious, advance to appropriate MRI and referral instead of assuming superficial means benign.
Common pitfall: Do not interpret the 5-cm triage threshold as a benignity rule. Small masses can be malignant, and suspicious features override size-based reassurance during assessment.
26.Why should MRI local staging precede biopsy of a suspicious soft tissue tumour?
MRI defines tumour extent, tissue compartments and relationships to neurovascular structures before biopsy-related haemorrhage or oedema can complicate interpretation. It also helps identify viable tissue for sampling and supports a biopsy route compatible with subsequent treatment. For a suspicious mass, imaging and specialist planning should therefore precede biopsy. The sequence protects both diagnostic information and future surgical options rather than treating biopsy as an isolated preliminary step.
Apply it
A deep thigh mass is suspicious for sarcoma and has not been biopsied. Obtain appropriate MRI local staging and specialist input first, allowing the biopsy target and tract to be planned with the eventual treatment approach.
Common pitfall: Do not perform an unplanned biopsy merely to obtain a quick diagnosis. Its tract and resulting tissue changes can complicate subsequent staging and definitive treatment.
27.Which soft tissue masses warrant specialist tumour-centre assessment?
A large, deep, enlarging or otherwise suspicious soft tissue mass warrants assessment through a specialist tumour pathway, particularly when imaging is indeterminate or suggests malignancy. Referral should occur before biopsy or excision when sarcoma is suspected. The aim is coordinated imaging, sampling and treatment planning. A benign-sounding symptom history, absence of pain or apparently circumscribed margins cannot independently exclude a clinically significant soft tissue tumour.
Apply it
A painless deep mass has enlarged over several months and measures 8 cm on imaging. Arrange specialist tumour-centre assessment before attempted excision, even if the lesion appears well defined and the patient reports little functional limitation.
Common pitfall: Do not use lack of pain as a reason for reassurance. Soft tissue malignancy can present as a painless enlarging mass with deceptively smooth margins.
Neuroradiologynot stated
28.How do diffusion-weighted images and ADC confirm restricted diffusion?
Restricted diffusion is supported by high signal on appropriately diffusion-weighted images together with low apparent diffusion coefficient. The ADC map helps separate reduced water mobility from signal influenced by T2 weighting. In acute ischaemia, cellular energy failure produces cytotoxic oedema and reduced extracellular water movement. However, restricted diffusion is a physical observation rather than a diagnosis, so distribution, other sequences and clinical timing remain essential to interpretation.
Apply it
A patient develops sudden focal weakness, and MRI shows a vascular-territory lesion bright on diffusion-weighted imaging and dark on ADC. Recognise true restricted diffusion supporting acute infarction in the matching clinical and anatomical context.
Common pitfall: Do not diagnose acute infarction from diffusion brightness alone. Confirm ADC reduction and consider lesion distribution, because several nonischaemic processes can also restrict diffusion.
ESR Essentials: Diffusion-Weighted MRI—Practice Recommendations by ESMRMB
29.Why can T2 shine-through mimic restricted diffusion?
Diffusion-weighted images retain T2 sensitivity, so tissue with prolonged T2 signal can remain bright even without reduced diffusivity. This is T2 shine-through. A normal or increased ADC supports that explanation rather than true restriction. Reading the diffusion image and ADC map together therefore tests the mechanism underlying brightness. The distinction is particularly useful when a lesion is strikingly T2 hyperintense or clinical timing does not support an acute event.
Apply it
A T2-bright brain lesion is also bright on diffusion-weighted imaging, but its ADC is elevated. Explain that the diffusion appearance reflects shine-through rather than using brightness alone to label the lesion as acutely restricted tissue.
Common pitfall: Do not call diffusion restriction when ADC is elevated simply because the diffusion image looks bright. T2 contribution can dominate the observed signal in lesions.
ESR Essentials: Diffusion-Weighted MRI—Practice Recommendations by ESMRMB
30.How does ADC evolution complicate the dating of cerebral infarction?
ADC is typically reduced early in infarction, then rises during evolution and may transiently approach normal values before becoming elevated. This pseudonormalisation means an apparently normal ADC does not necessarily exclude an evolving infarct. Diffusion brightness may persist partly because of T2 effects. Dating therefore requires the symptom history, other MRI sequences and lesion appearance rather than a single ADC measurement interpreted independently of time.
Apply it
A patient presents after several days of neurological symptoms. A vascular-territory lesion remains diffusion-bright but has near-normal ADC. Consider evolving infarction with ADC pseudonormalisation and integrate the other sequences rather than declaring the study inconsistent with infarction.
Common pitfall: Do not use a near-normal ADC as a universal exclusion test for infarction. The relationship between ADC and ischaemic injury changes during lesion evolution.
ESR Essentials: Diffusion-Weighted MRI—Practice Recommendations by ESMRMB
Oncologic Imagingnot stated
31.How are RECIST target lesions selected and measured consistently?
RECIST 1.1 selects up to five target lesions overall, with no more than two per organ. Non-nodal measurable targets generally require a longest diameter of at least 10 mm on suitable CT, while target lymph nodes require a short axis of at least 15 mm. Consistent technique and lesion selection support reproducible comparisons. Nodal short-axis measurements and non-nodal longest-axis measurements must not be interchanged during follow-up.
Apply it
Baseline CT shows several liver lesions and enlarged nodes. Select representative measurable targets within the overall and per-organ limits. Record liver longest diameters and nodal short axes so later sums compare the same lesions using the same conventions.
Common pitfall: Do not measure a target lymph node by its longest axis. RECIST nodal eligibility and follow-up use the short axis, unlike most non-nodal lesions.
32.Which comparison establishes RECIST partial response?
RECIST 1.1 partial response requires at least a 30% decrease in the target-lesion sum from the baseline sum. Baseline is the reference for this response threshold, rather than the most recent scan or the nadir. Overall response also requires consideration of non-target disease and new lesions. A favourable target-lesion calculation therefore cannot independently establish an overall partial response when another component shows unequivocal progression.
Apply it
The baseline target sum is 100 mm and the current sum is 68 mm, a 32% reduction. With no new lesions or disqualifying non-target progression, the target-lesion change supports partial response rather than stable disease.
Common pitfall: Do not calculate partial response from the immediately preceding scan. The required reference is baseline, and new lesions can override an apparently favourable target sum.
33.When does target-lesion growth meet RECIST progression criteria?
Target-lesion progression requires at least a 20% increase in the sum relative to the smallest recorded sum, together with an absolute increase of at least 5 mm. Both conditions must be satisfied. The reference is the nadir, including baseline if that remains the smallest sum. New lesions and unequivocal non-target progression are additional progression pathways, so target measurements represent one component of the complete response assessment.
Apply it
A target sum falls to a nadir of 40 mm and later rises to 48 mm. The 20% increase also adds 8 mm, satisfying both target-progression thresholds even though the sum may remain below its original baseline.
Common pitfall: Do not compare progression only with baseline or apply the percentage threshold alone. Small absolute changes can exceed 20% without meeting the additional 5-mm requirement.
Paediatric Radiologynot stated
34.Which imaging test evaluates suspected hypertrophic pyloric stenosis?
Ultrasound is the appropriate initial imaging test for an infant with a clinical presentation suggesting hypertrophic pyloric stenosis, classically progressive nonbilious vomiting. It directly assesses pyloric muscle and canal morphology and permits observation of opening and gastric passage. The examination should answer the suspected obstructive mechanism without ionising radiation. Clinical age, symptom pattern and dynamic findings matter; nonbilious vomiting alone does not establish pyloric stenosis.
Apply it
A five-week-old infant has progressive projectile nonbilious vomiting and remains hungry after feeds. Request pyloric ultrasound to assess muscular thickening, canal morphology and passage, rather than beginning with a radiation-based examination intended for another obstructive question.
Common pitfall: Do not apply the pyloric pathway to bilious vomiting. Bile-stained emesis raises a different anatomical concern and requires prompt assessment for potentially dangerous intestinal obstruction.
35.Why does bilious infant vomiting require an intestinal rotation assessment?
Bilious vomiting can indicate obstruction beyond the entry of bile into the duodenum and raises concern for malrotation with volvulus. In the appropriate infant presentation, an upper gastrointestinal contrast examination evaluates duodenal course and the duodenojejunal junction. This is a different diagnostic question from pyloric muscle assessment. Imaging selection must reflect age, examination findings and available abdominal radiographs, while urgent clinical assessment proceeds when volvulus is suspected.
Apply it
A young infant has green vomiting and a nonclassic abdominal gas pattern, with malrotation suspected. Arrange urgent assessment and an appropriate upper gastrointestinal contrast examination rather than limiting the work-up to an ultrasound of the pylorus.
Common pitfall: Do not allow a nondiagnostic or unremarkable plain radiograph to settle suspected malrotation. The relevant question concerns intestinal rotation and possible volvulus, not pyloric morphology.
36.How does dynamic pyloric assessment distinguish persistent obstruction from spasm?
Pyloric ultrasound combines morphology with observation over time. Persistent muscular thickening and canal elongation with impaired passage support hypertrophic pyloric stenosis, whereas transient narrowing that relaxes and permits passage may reflect pylorospasm. A single contracted image can therefore mislead. When findings are borderline, careful dynamic reassessment and the clinical trajectory are more useful than forcing a definitive diagnosis from one isolated measurement or momentary appearance.
Apply it
During ultrasound for nonbilious vomiting, an initially narrowed pylorus subsequently opens with passage of gastric contents. Reassess the complete morphology and dynamic sequence before diagnosing fixed pyloric obstruction from the first captured image alone.
Common pitfall: Do not diagnose fixed obstruction from transient contraction alone. Dynamic opening and passage provide important evidence that static measurements or a single image may omit.
Urogenital Radiologynot stated
37.What qualifies as a cystic renal mass in Bosniak version 2019?
Bosniak version 2019 defines a cystic renal mass as one with less than approximately 25% enhancing tissue. This boundary helps distinguish a genuinely cystic mass from a predominantly solid tumour with necrosis. The classification describes imaging features rather than proving histology. Apply it only after assessing enhancement and excluding processes such as infection, inflammation or vascular disease that require a different diagnostic framework.
Apply it
A renal lesion has central fluid but a large enhancing solid component comprising most of its volume. Assess it as a predominantly solid mass with necrosis rather than assigning a Bosniak category simply because fluid is present.
Common pitfall: Do not classify every fluid-containing renal lesion as a Bosniak cystic mass. Necrotic solid tumours and non-neoplastic processes can fall outside its intended application.
38.How do enhancing renal walls and septa distinguish Bosniak IIF from III?
Bosniak version 2019 makes wall and septal thickness more explicit: thin is 2 mm or less, minimally thickened is 3 mm, and thick is 4 mm or more. A smooth, enhancing 3-mm wall or septum can support IIF, whereas an enhancing thick wall or septum supports III. Enhancement, thickness, number and surface morphology must be assessed together rather than classifying a lesion from the word complex.
Apply it
Contrast MRI demonstrates a smooth enhancing wall measuring 3 mm without a nodule. That feature supports IIF. If the enhancing wall instead measures 4 mm, the thickness criterion supports III, assuming the remaining assessment is compatible.
Common pitfall: Do not round away the defined thickness distinctions or ignore enhancement. The classification depends on specified imaging features, not a nonspecific impression of cyst complexity.
39.Which enhancing protrusions qualify as Bosniak IV nodules?
In Bosniak version 2019, an enhancing convex protrusion qualifies as a nodule if it has acute margins with the wall or septum at any size, or obtuse margins and measures at least 4 mm. Nodules support category IV. Smaller obtuse protrusions can instead represent irregular thickening. Thus, enhancement, margin geometry and size distinguish a nodule from irregularity and should be described explicitly in the report.
Apply it
A cystic renal mass contains a 3-mm enhancing convex protrusion with acute margins where it meets the wall. Recognise a nodule supporting Bosniak IV despite its size, because the acute-margin criterion has no minimum size.
Common pitfall: Do not apply the 4-mm threshold to every protrusion. It applies to obtuse-margin nodules; an enhancing acute-margin protrusion qualifies as a nodule at any size.
Nuclear Medicine as Basic Trainingnot stated
40.Why is FDG uptake not specific for malignancy?
FDG accumulation reflects glucose utilisation and occurs in metabolically active inflammatory cells as well as many malignant tissues. Uptake therefore identifies biological activity rather than cancer-specific histology. Interpretation requires the anatomical distribution, CT findings, clinical indication and relevant inflammatory history. Neither visual intensity nor an isolated uptake value reliably separates every infection or inflammatory process from malignancy, particularly when the possible processes overlap anatomically.
Apply it
FDG PET shows avid tissue around a clinically infected prosthesis. Interpret the uptake within the infection-focused indication and anatomical findings rather than relabelling it as malignant solely because the activity is visually intense on PET.
Common pitfall: Do not use FDG avidity as a synonym for cancer. Infection, sterile inflammation and malignancy can all produce substantial uptake with overlapping appearances on PET.
EANM/SNMMI Guideline for FDG PET in Infection and Inflammation
41.How can recent vaccination alter lymph-node FDG interpretation?
Vaccination can activate immune tissue and produce FDG uptake at the injection site and in draining lymph nodes. Knowing the vaccination date and side helps explain a corresponding regional pattern and prevents automatic attribution to disease progression. Nodal morphology, distribution and the patient's underlying disease still determine whether observation or further assessment is appropriate. Vaccination history does not exclude concurrent malignant disease. Direct primary evidence is provided by the original vaccination PET/CT cohort study: https://pubmed.ncbi.nlm.nih.gov/34156552/.
Apply it
A patient has new left axillary uptake shortly after vaccination in the left arm. Review the injection history and CT morphology, and describe the plausible reactive explanation while considering whether the distribution matches the patient's known disease.
Common pitfall: Do not ignore vaccination history, but do not let it explain every node automatically. Discordant morphology or distribution still requires assessment, and reactive and malignant nodes can coexist.
EANM/SNMMI Guideline for FDG PET in Infection and Inflammation
42.How is physiological urinary FDG activity distinguished from a pathological focus?
FDG is excreted through the urinary system, so renal collecting systems, ureters and bladder can show intense physiological activity. Anatomical correlation is essential when a urinary focus lies near a suspected lesion. Trace the expected urinary course and inspect the CT component rather than assuming a bright pelvic focus is pathological. Physiological excretion may also obscure adjacent disease, so absence of a clearly separate focus does not guarantee absence of pathology.
Apply it
A focal pelvic PET hotspot lies along the expected ureteric course without a corresponding mass on CT. Consider urinary tracer activity and review adjacent images before classifying it as a metastatic node or inflammatory lesion.
Common pitfall: Do not interpret PET intensity without localisation. Urinary activity can imitate disease or obscure nearby abnormalities, particularly in the pelvis and around collecting systems.
EANM/SNMMI Guideline for FDG PET in Infection and Inflammation
Radiation Protection Education and Trainingnot stated
43.How does justification determine whether an imaging exposure should occur?
Justification asks whether the expected benefit of an exposure outweighs its radiation detriment in the particular clinical situation. It requires a meaningful diagnostic or management question, consideration of existing information and assessment of suitable alternatives. A technically low-dose examination can still be unjustified if it offers no useful benefit. Conversely, radiation exposure can be justified when imaging supplies information likely to improve a consequential clinical decision.
Apply it
A repeat CT is requested although a recent adequate examination already answers the unchanged clinical question. Review the prior study and indication before exposing the patient again; reducing the repeat scan's dose would not resolve its lack of benefit.
Common pitfall: Do not confuse a low dose with a justified examination. The decision to expose must be supported by expected clinical benefit before technical optimisation begins.
44.Why does optimisation require diagnostically adequate image quality?
Optimisation seeks an exposure appropriate to the clinical purpose while maintaining the image quality needed to answer the question. It does not mean choosing the lowest technically achievable dose regardless of diagnostic performance. Patient size, examination task, scan coverage and protocol settings influence the balance. Excessive noise or incomplete coverage can undermine benefit and cause repeat imaging, so image adequacy must be considered alongside dose reduction.
Apply it
A protocol reduction makes images too noisy to assess the small structure central to the referral. Reconsider the settings against the diagnostic task rather than accepting the lowest dose value as evidence that the examination is optimised.
Common pitfall: Do not optimise dose in isolation from diagnostic performance. An unreadable low-dose study can fail its clinical purpose and expose the patient again through repetition.
45.What does a diagnostic reference level tell a radiology service?
A diagnostic reference level is an investigation tool for comparing typical exposure levels for a defined imaging task and patient group. Repeatedly high typical values should prompt review of practice and optimisation opportunities. A DRL is not an individual patient dose limit or a boundary between safe and unsafe examinations. Comparisons must use appropriate dose quantities, clinical tasks and patient categories so that the benchmark is meaningful.
Apply it
An audit finds the typical dose for a standard adult CT task consistently above the relevant DRL. Review protocol design, patient matching and image adequacy, rather than cancelling an individual clinically justified examination solely because its dose exceeds that benchmark.
Common pitfall: Do not treat a DRL as a legal ceiling for each patient or assume that values below it prove an examination is justified and optimised.
Principles of Imaging Technology and Molecular Imagingnot stated
46.How does CT quantum noise change with tube-current–time product?
Under otherwise comparable acquisition and reconstruction conditions, quantum noise varies approximately inversely with the square root of tube-current–time product. Doubling mAs therefore reduces noise to about 0.71 of its previous value, while quadrupling mAs approximately halves it. Radiation output rises approximately with mAs when other settings remain fixed. This relationship explains why substantial exposure increases produce diminishing improvements in noise rather than proportionate image-quality gains.
Apply it
A protocol uses 100 mAs and has a measured noise level of 20 units. Increasing to 400 mAs would predict roughly 10 units under comparable conditions, but approximately four times the exposure rather than twice.
Common pitfall: Do not assume that doubling mAs halves noise. The square-root relationship means halving quantum noise requires approximately four times the mAs under comparable conditions.
AAPM Task Group 202: Physical Uncertainties in Light Ion Beam Treatments
47.What does a Hounsfield unit measure?
The Hounsfield scale expresses CT attenuation relative to water: HU equals 1000 times the difference between tissue and water attenuation divided by water attenuation. Water is approximately 0 HU and air approximately −1000 HU. The value describes attenuation under the acquisition conditions rather than tissue identity by itself. Beam energy, contrast material, partial volume and artefacts can affect measurements, so interpretation requires appropriate region placement and image context.
Apply it
A homogeneous region measures approximately 0 HU on an appropriate unenhanced image. Recognise water-like attenuation, then inspect morphology and partial-volume effects before deciding whether the region represents a simple fluid structure or another low-attenuation process.
Common pitfall: Do not treat a single HU value as histology. Different materials can overlap, and contrast, acquisition conditions or partial volume can change the measured attenuation.
AAPM Task Group 202: Physical Uncertainties in Light Ion Beam Treatments
48.Why must CT noise comparisons hold reconstruction and geometry constant?
The simple inverse-square-root exposure relationship assumes comparable conditions. Slice thickness, reconstruction method, reconstruction kernel, patient attenuation and acquisition settings also affect image noise and its texture. A change in measured noise cannot therefore be attributed to mAs alone when several parameters differ. Protocol evaluation should compare a defined imaging task under controlled conditions and examine whether clinically relevant structures remain detectable, not merely whether a noise number decreases.
Apply it
Two CT series use different mAs, slice thicknesses and reconstruction kernels. Avoid attributing their noise difference solely to exposure. Compare matched reconstructions or account for the other changes before recommending a protocol adjustment for the diagnostic task.
Common pitfall: Do not apply the square-root rule across unmatched protocols as an exact prediction. Reconstruction and patient differences can invalidate the assumed comparison between noise measurements.
AAPM Task Group 202: Physical Uncertainties in Light Ion Beam Treatments
Medical Imaging Informaticsnot stated
49.How does modality worklist reduce patient and examination transcription errors?
DICOM Modality Worklist provides scheduled procedure and patient information to imaging equipment, reducing repeated manual entry of identifiers and examination details. The modality selects the appropriate scheduled item and uses its supplied information during acquisition. This improves consistency but depends on correct source data and correct selection. Worklist availability therefore supports identity management; it does not remove the need to verify the patient and intended examination before imaging.
Apply it
A technologist finds two patients with similar names on the worklist. Match additional identifiers and the requested procedure before selecting the item, rather than assuming that an electronically populated demographic record must belong to the patient present.
Common pitfall: Do not regard worklist population as proof of correct identity. Selecting the wrong scheduled item can propagate accurate information about the wrong patient into an examination.
50.Which DICOM operation queries a modality worklist?
The Modality Worklist Information Model uses C-FIND to query matching scheduled procedure information. The request supplies matching keys and requests supported return information; the provider returns matching worklist items according to its conformance. This query function differs from image storage or retrieval. Understanding that distinction helps isolate workflow failures: missing schedule results concern worklist communication and matching rather than automatically indicating a problem with image transfer.
Apply it
A scanner can send completed images to the archive but cannot retrieve scheduled appointments. Investigate the modality worklist C-FIND configuration and matching criteria rather than assuming that successful image storage proves the worklist service is functioning.
Common pitfall: Do not confuse C-FIND worklist querying with image storage. Different DICOM services can succeed or fail independently within the same imaging equipment and network.
51.Why does a scheduled worklist item not prove a procedure was performed?
A modality worklist describes planned imaging activity and associated patient and procedure information. Scheduling information does not establish that acquisition occurred, that the procedure was completed or that images reached the archive. Those are separate workflow facts requiring their own evidence. Distinguishing planned from performed activity prevents administrative states from being mistaken for clinical completion and helps reconcile cancelled, rescheduled or interrupted examinations accurately within an imaging service.
Apply it
A scheduled CT remains visible on the worklist after the patient leaves before scanning. Confirm the actual acquisition and workflow status rather than telling the clinician that imaging is complete merely because a worklist item exists.
Common pitfall: Do not infer clinical completion from scheduling data. A valid worklist item can exist for a procedure that was cancelled, deferred or never started.
Communication and Managementnot stated
52.When does an urgent imaging finding require direct communication?
A finding requiring urgent action needs communication that reaches an appropriate clinician in time to influence care. Merely issuing a routine report may be insufficient when delay could cause harm. Use a direct route suited to the urgency, seek acknowledgement and escalate if the intended recipient cannot be reached. The communication should convey the finding, its significance and the need for timely clinical attention alongside the formal report.
Apply it
An outpatient CT reveals an immediately consequential acute aortic abnormality. Contact an appropriate responsible clinician directly and confirm receipt, escalating through the service's urgent pathway if necessary rather than relying on eventual routine report review.
Common pitfall: Do not equate report availability with successful urgent communication. A report can be technically accessible while no responsible clinician has received its time-critical message.
53.How should an imaging report connect findings to the clinical question?
A useful report identifies the examination and relevant technique, presents meaningful findings and provides a clear conclusion addressing the clinical question. Comparison studies, limitations and justified recommendations should be explicit when they affect interpretation. The conclusion synthesises rather than merely repeats observations. Distinguishing observed features from diagnostic interpretation helps the reader understand certainty and supports appropriate action without forcing them to reconstruct the radiologist's reasoning from a long unprioritised list.
Apply it
A scan excludes the suspected obstruction but reveals an alternative explanation for symptoms. State both conclusions clearly, identify any material technical limitation and recommend additional assessment only when it addresses a specific unresolved clinical question.
Common pitfall: Do not bury the answer in a descriptive catalogue. A detailed findings section cannot compensate for an unclear conclusion or a recommendation lacking a defined purpose.
54.What should be documented after communicating a consequential result?
Document the clinically important message, the recipient, the time and method of communication, and any acknowledgement or escalation relevant to ensuring receipt. When a material discrepancy changes an earlier interpretation, the corrected information must reach the responsible team rather than merely appearing in an addendum. Documentation makes the communication traceable, while active confirmation addresses whether the information actually arrived in time to influence patient care.
Apply it
A final review identifies a consequential finding missed in the preliminary report. Contact the responsible clinician, explain the changed interpretation and document whom you reached and when. Add the formal correction so the report and communication record agree.
Common pitfall: Do not assume an addendum alone closes a material discrepancy. The corrected finding may require active communication because the team has already acted on the preliminary interpretation.
Research and Evidence-Based Medicinenot stated
55.How are sensitivity and specificity distinguished by their denominators?
Sensitivity is the proportion of people with disease who test positive: true positives divided by true positives plus false negatives. Specificity is the proportion without disease who test negative: true negatives divided by true negatives plus false positives. Both begin with reference-standard disease status. Keeping the denominator explicit prevents confusing test performance with the probability of disease after a result, which is a predictive-value question.
Apply it
Among 100 people with disease, a test identifies 90; among 200 without disease, it correctly excludes 180. Sensitivity is 90/100 and specificity is 180/200, both 90%, despite the groups having different sizes in this study.
Common pitfall: Do not put all positive results in the sensitivity denominator. That denominator calculates positive predictive value, whereas sensitivity begins with everyone who truly has disease.
56.Why does disease prevalence affect the meaning of a positive result?
Positive predictive value is the proportion of positive results that are true positives. Even when sensitivity and specificity remain constant, lower disease prevalence generally reduces positive predictive value because false positives arise from a larger disease-free group. Negative predictive value generally increases as prevalence falls. Consequently, a positive imaging test does not carry an identical probability of disease in a low-risk screening population and a high-risk diagnostic population.
Apply it
The same test is used in an asymptomatic low-risk group and a clinically selected high-risk group. Expect a greater proportion of false positives among positive results in the low-risk group, assuming comparable sensitivity and specificity.
Common pitfall: Do not quote a study's predictive value as universal. Its disease prevalence and patient selection may differ materially from those of the patient or service being assessed.
57.How does a two-by-two table reveal the false-positive burden?
A two-by-two table separates true positives, false positives, false negatives and true negatives using test result and reference-standard disease status. It permits direct calculation of accuracy measures and shows the absolute workload created by false results. Percentages alone can hide that burden, especially when disease is uncommon. Reconstructing expected counts for a defined population makes the practical implications of sensitivity, specificity and prevalence easier to judge.
Apply it
In 1,000 people with 10% disease prevalence, a 90%-sensitive and 90%-specific test yields 90 true positives and 90 false positives. Half of positive results are therefore false, despite apparently favourable sensitivity and specificity values.
Common pitfall: Do not subtract specificity from sensitivity to estimate predictive value. Construct the disease and non-disease groups first, then calculate the relevant result-based denominator explicitly.
Sustainability in Radiologynot stated
58.Why is reducing low-value imaging a sustainability intervention?
An examination without sufficient clinical value consumes equipment time, energy and materials without corresponding patient benefit. Avoiding such imaging can therefore reduce environmental impact while preserving resources for useful care. The decision must remain grounded in clinical appropriateness, not a blanket preference for fewer examinations. Reviewing duplicate requests and existing studies is particularly useful because it can remove unnecessary activity before any acquisition-related resources are consumed.
Apply it
A repeat examination is requested even though a recent accessible study answers the unchanged question. Resolve whether new imaging would alter care before scheduling it, combining appropriate clinical use with avoidance of unnecessary environmental and operational costs.
Common pitfall: Do not equate sustainable practice with denying beneficial imaging. The target is avoidable low-value activity while maintaining access to examinations that meaningfully support patient care.
Sustainability in Radiology: Multisociety Position Paper and Call to Action
59.How should environmental improvements in radiology be measured?
Environmental assessment needs a defined boundary, baseline and clinically meaningful unit of comparison. Energy per examination, total energy consumption and life-cycle emissions answer different questions and should not be interchanged. A change that reduces one visible input may increase another outside the chosen boundary. Measure the intended outcome while checking image adequacy, workflow and repeat rates so that apparent environmental savings do not depend on diminished clinical performance.
Apply it
A department introduces a shorter protocol. Compare environmental measures before and after implementation using consistent boundaries, and check whether repeat examinations increase. A lower energy figure per acquisition may not represent a net improvement if additional imaging is required.
Common pitfall: Do not infer a carbon reduction directly from shorter scan time. Equipment behaviour, electricity sources, repeat imaging and the assessment boundary influence the actual environmental result.
Sustainability in Radiology: Multisociety Position Paper and Call to Action
60.What does equipment life-cycle assessment add to procurement decisions?
Life-cycle assessment considers environmental effects across equipment production, transport, installation, operation, maintenance and end-of-life handling. It prevents procurement decisions from focusing only on electricity use during scanning. Extending useful life or selecting more efficient equipment can have different implications depending on operational performance and embodied impacts. A sound comparison uses equivalent clinical capability and a defined service period rather than assuming that either replacement or retention is inherently preferable.
Apply it
A service compares maintaining a functioning scanner with purchasing a replacement. Evaluate manufacturing and disposal impacts alongside expected operational savings, reliability and clinical capability over a common time horizon before concluding which option has the lower environmental burden.
Common pitfall: Do not assume a new scanner is environmentally superior solely because it uses less power while scanning. Production impacts and the existing equipment's remaining useful life matter.
European Training Curriculum for Radiology: Edition March 2025 · Sustainability in Radiology: Multisociety Position Paper and Call to Action
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Use the full March 2025 Level I–II curriculum to identify omissions; this 60-concept selection covers all 20 selected domains but does not exhaust EDiR scope.
- Practise image-based distinctions: subendocardial versus nonischaemic enhancement, honeycombing versus dilated airways, restricted diffusion versus shine-through, and renal nodules versus irregular thickening.
- Memorise decision-linked thresholds with their reference system: ACR TI-RADS size criteria, Bosniak version 2019 morphology and RECIST baseline-versus-nadir comparisons.
- Rehearse short-case answers that connect the decisive imaging finding to classification, complications, the next investigation and timely communication.
- Include imaging pharmacology, contrast media and radiopharmaceuticals in broader curriculum study; EBR explicitly lists them among recurring examination categories.
- Integrate physics, protection, informatics, communication, evidence interpretation and sustainability into clinical cases rather than studying them only as isolated definitions.
A practical preparation plan
1. Map the complete curriculum
Read the official Level I–II contents and build a coverage map. Distinguish curriculum chapters from EBR's recurring examination categories, and identify subjects requiring resources beyond this selective guide.
2. Learn the discriminating feature
For each concept, state the feature that changes the interpretation or management. Pair it with the tempting alternative: for example, ADC reduction versus diffusion brightness, or ascending involvement versus entry-tear location.
3. Practise calculations and thresholds
Calculate ventricular ejection fraction, CT noise changes, RECIST response and predictive values without relying on answer choices. Name the denominator, reference scan or classification version before calculating.
4. Develop image-based case reasoning
Work through representative images across the full curriculum. Give a concise finding, interpretation and consequential next step, including complications and communication where relevant. Add short-case and CORE-style reasoning practice alongside these single-best-answer drills.
5. Review errors by mechanism
Complete the 20 questions, then explain why each alternative fails. Classify errors as missed imaging cues, incorrect thresholds, wrong comparison references or communication failures, and revisit the corresponding primary reference.
6. Confirm sitting-specific arrangements
Before the examination, review current EBR instructions for eligibility, recognition, timing and delivery. Keep those logistics separate from the clinical knowledge and reasoning required by the curriculum.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- European Board of Radiology
- EDiR
- All about the examination
- EDiR FAQs
- ESR Training Curricula
- European Training Curriculum for Radiology: Edition March 2025
- ACR Mammography Sample Lay Report Letters
- ACR Reporting: Mammography
- SCMR Stress Perfusion Template
- American Thoracic Society: Combing Through the Honeycomb
- 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease
- EASL Clinical Practice Guidelines on the Management of Benign Liver Tumors
- A Lexicon for First-Trimester US: Society of Radiologists in Ultrasound Consensus Conference Recommendations
- ACR Thyroid Imaging Reporting and Data System
- ACR TI-RADS Assessment Categories: Alternative Chart
- CIRSE Clinical Practice Manual
- ESSR Guidelines 2023: Soft Tissue Tumor Imaging in Adults
- ESR Essentials: Diffusion-Weighted MRI—Practice Recommendations by ESMRMB
- RECIST 1.1 Guidelines for Solid Tumors
- ACR/RSNA Appropriateness Criteria: Vomiting in Infants
- Bosniak Classification of Cystic Renal Masses, Version 2019
- EANM/SNMMI Guideline for FDG PET in Infection and Inflammation
- IAEA International Basic Safety Standards
- AAPM Task Group 202: Physical Uncertainties in Light Ion Beam Treatments
- DICOM PS3.4: Modality Worklist SOP Class
- ESR Communication Guidelines for Radiologists
- CDC Principles of Epidemiology: Lesson 5, Appendix A
- Sustainability in Radiology: Multisociety Position Paper and Call to Action
- ESUR-Guidelines-10_0-Final-Version.pdf
- RECISTGuidelines.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.